Black Fungus: Maharashtra caps treatment rates for private hospitals
In a major relief for patients suffering from mucormycosis (black fungus), the Maharashtra government on Friday announced a cap on the treatment rates charged by private hospitals.
Chief Minister Uddhav Thackeray has approved a proposal by the Health Ministry fixing the charges to be levied by all private hospitals, till July 31, to make it affordable for the common man.
The development comes a fortnight after the state government issued an order on May 18 to provide free treatment, including medicines, beds, etc, to mucormycosis patients under the Mahatma Jyotiba Jan Arogya Yojana and the Pradhan Mantri Jan Arogya Yojana, at 130 pre-determined hospitals, besides empaneling another 1000 hospitals.
There are around 2,000 black fungus cases in the state currently with more than 150 deaths recorded till date, which are considered the highest in the country, according to officials.
The order issued by the state government classifies areas in thee categories, A, B and C categories and different rates have been fixed for the three.
In the A class, under which Mumbai, Pune and Nagpur fall, the daily treatment rate for ward patients has been capped at Rs4,000. The rates for intensive care unit (ICU) without ventilator and ICU with ventilator support have been fixed at Rs7,500 and Rs9,000, respectively
For the B category, comprising Nasik, Amravati, Aurangabad, Bhiwandi, Solapur, Kolhapur, Vasai Virar, Malegaon, Nanded and Sangli, daily rate for ward treatment has been fixed at Rs3,000. The rates for ICU with and without ventilator support have been capped at Rs5,500 and Rs6,700, respectively.
In the remaining areas in the state, which are classified under C class, the rates have been capped at Rs2,400 for wards, Rs4,500 for ICU without ventilator and Rs5,400 for ICU with ventilator support.
These rates do not cover costs of high-end drugs or diagnostic procedures such as CT scans and MRI, the order says. The order has also capped rates for surgical procedures, with separate charges applicable for A, B and C categories.
Disclaimer: Information, facts or opinions expressed in this news article are presented as sourced from IANS and do not reflect views of Moneylife and hence Moneylife is not responsible or liable for the same. As a source and news provider, IANS is responsible for accuracy, completeness, suitability and validity of any information in this article.
Corona Virus (COVID-19) Latest Updates
IANS 09 June 2021
India records over 92,000 Covid cases, 2,219 deaths in 24 hours
09-06-2021 09:50

India on Wednesday logged 92,596 new Covid infections in 24 hours, less than one lakh cases for the second straight day and 6,098 cases more...
Won't Permit 'Experiments with Faulty Ventilators' Supplied through PM CARES Fund: Bombay HC
IANS 03 June 2021
In a significant ruling, the Bombay High Court has said that it would be the responsibility of the Centre in case any faulty ventilators supplied by a Gujarat company through the PM CARES Fund cause deaths of COVID-19...
After Pfizer, Moderna, now SII seeks indemnity from liability: Sources
IANS 03 June 2021
Pune-based Serum Institute of India (SII), which manufactures Covishield, has also sought indemnity from liability, expressing the hope that rules would be the same for everyone, said sources.
This comes as the Centre is...
'Arbitrary, Irrational': SC on Centre's Vaccine Policy for 18-44 Yrs
IANS 02 June 2021
The Supreme Court on Wednesday made scathing remarks on Centre's vaccination policy against COVID-19, terming the replacement of free vaccination in the first two phases with paid vaccination for persons between 18-44 years as prima...
Free Helpline
Legal Credit